Asia Pacific Small Molecule API Market 2022-2032 by Source (Synthetic, Semi-synthetic, Natural), Product Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Country: Trend Forecast and Growth Opportunity
Asia Pacific small molecule API market will grow by 8.7% annually with a total addressable market cap of over $1 trillion over 2023-2032, driven by the increasing incidences of diseases, the development of high-potency small molecule APIs, patents expiry of the top-selling pharmaceuticals, the increasing technological developments in manufacturing sector, and a surging healthcare expenditure.
Highlighted with 67 tables and 51 figures, this 131-page report “Asia Pacific Small Molecule API Market 2022-2032 by Source (Synthetic, Semi-synthetic, Natural), Product Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific small molecule API market in every aspect of the classification from perspectives of Source, Product Type, Therapeutic Area, Application, Manufacturer Type, and Country.
Based on Source, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Semi-synthetic API
• Natural Origin
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Standard API
• High Potency API (HPAPI)
o Branded HPAPI
o Generic HPAPI
By Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Metabolic Diseases
• Other Therapeutic Areas
By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Clinical Use
• Commercial Use
By Manufacturer Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Pharmaceutical Companies
• CMOs
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Product Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aurobindo Pharma Ltd.
Cambrex Corporation
Catalent Inc.
Dr. Reddy's Laboratories
GlaxoSmithKline plc
Lonza Group
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Wuxi AppTec Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 24
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 26
2.2 Major Growth Drivers 30
2.3 Market Restraints and Challenges 34
2.4 Emerging Opportunities and Market Trends 37
2.5 Porter’s Fiver Forces Analysis 41
3 Segmentation of Asia Pacific Market by Source 45
3.1 Market Overview by Source 45
3.2 Synthetic API 47
3.2.1 Branded Synthetic API 48
3.2.2 Generic Synthetic API 49
3.3 Semi-synthetic API 50
3.4 Natural Origin 51
4 Segmentation of Asia Pacific Market by Product Type 52
4.1 Market Overview by Product Type 52
4.2 Standard API 54
4.3 High Potency API (HPAPI) 55
4.3.1 Branded HPAPI 56
4.3.2 Generic HPAPI 57
5 Segmentation of Asia Pacific Market by Therapeutic Area 58
5.1 Market Overview by Therapeutic Area 58
5.2 Infectious Diseases 60
5.3 Oncology 61
5.4 Ophthalmology 62
5.5 Cardiovascular Disorders 63
5.6 Central Nervous System 64
5.7 Respiratory Disorders 65
5.8 Metabolic Diseases 66
5.9 Other Therapeutic Areas 67
6 Segmentation of Asia Pacific Market by Application 68
6.1 Market Overview by Application 68
6.2 Clinical Use 70
6.3 Commercial Use 71
7 Segmentation of Asia Pacific Market by Manufacturer Type 72
7.1 Market Overview by Manufacturer Type 72
7.2 Pharmaceutical Companies 74
7.3 CMOs 76
8 Asia-Pacific Market 2022-2032 by Country 78
8.1 Overview of Asia-Pacific Market 78
8.2 Japan 81
8.3 China 84
8.4 Australia 86
8.5 India 88
8.6 South Korea 90
8.7 Rest of APAC Region 92
9 Competitive Landscape 94
9.1 Overview of Key Vendors 94
9.2 New Product Launch, Partnership, Investment, and M&A 97
9.3 Company Profiles 98
Aurobindo Pharma Ltd. 98
Cambrex Corporation 100
Catalent Inc. 101
Dr. Reddy's Laboratories 104
GlaxoSmithKline plc 107
Lonza Group 111
Merck & Co., Inc. 114
Mylan N.V. 116
Novartis AG 118
Pfizer Inc. 120
Sun Pharmaceutical Industries Ltd. 124
Teva Pharmaceutical Industries Ltd. 127
Wuxi AppTec Co., Ltd. 129
RELATED REPORTS 131
List of Tables:
Table 1. Snapshot of Asia Pacific Small Molecule API Market in Balanced Perspective, 2022-2032 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Scenarios for Economic Impact of Ukraine Crisis 27
Table 5. World Health Spending by Region, $ bn, 2013-2020 32
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 33
Table 7. Main Product Trends and Market Opportunities in Asia Pacific Small Molecule API Market 37
Table 8. Asia Pacific Small Molecule API Market by Source, 2022-2032, $ mn 45
Table 9. Asia Pacific Small Molecule API Market: Synthetic API by Drug Type, 2022-2032, $ mn 47
Table 10. Asia Pacific Small Molecule API Market by Product Type, 2022-2032, $ mn 52
Table 11. Asia Pacific Small Molecule API Market: HPAPI by Drug Type, 2022-2032, $ mn 55
Table 12. Asia Pacific Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 58
Table 13. Asia Pacific Small Molecule API Market by Application, 2022-2032, $ mn 68
Table 14. Asia Pacific Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 72
Table 15. APAC Small Molecule API Market by Country, 2022-2032, $ mn 79
Table 16. Japan Small Molecule API Market by Product Type, 2022-2032, $ mn 83
Table 17. Japan Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 83
Table 18. Japan Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 83
Table 19. China Small Molecule API Market by Product Type, 2022-2032, $ mn 85
Table 20. China Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 85
Table 21. China Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 85
Table 22. Australia Small Molecule API Market by Product Type, 2022-2032, $ mn 87
Table 23. Australia Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 87
Table 24. Australia Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 87
Table 25. India Small Molecule API Market by Product Type, 2022-2032, $ mn 89
Table 26. India Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 89
Table 27. India Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 89
Table 28. South Korea Small Molecule API Market by Product Type, 2022-2032, $ mn 91
Table 29. South Korea Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 91
Table 30. South Korea Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 91
Table 31. Small Molecule API Market in Rest of APAC by Country/Region, 2022-2032, $ mn 93
Table 32. Aurobindo Pharma Ltd.: Company Snapshot 98
Table 33. Aurobindo Pharma Ltd.: Business Segmentation 99
Table 34. Aurobindo Pharma Ltd.: Product Portfolio 99
Table 35. Cambrex Corporation: Company Snapshot 100
Table 36. Catalent Inc.: Company Snapshot 101
Table 37. Catalent Inc.: Business Segmentation in 2018 101
Table 38. Catalent Inc.: Product Portfolio 102
Table 39. Catalent Inc.: Revenue, 2018-2020, $ million 102
Table 40. Catalent Inc.: Revenue by Region in 2018 103
Table 41. Dr. Reddy's Laboratories: Company Snapshot 104
Table 42. Dr. Reddy's Laboratories: Business Segmentation 104
Table 43. Dr. Reddy's Laboratories: Revenue, 2018-2020, $ bn 105
Table 44. GlaxoSmithKline: Company Snapshot 107
Table 45. GlaxoSmithKline: Business Segmentation 108
Table 46. GlaxoSmithKline: Product Portfolio 109
Table 47. GlaxoSmithKline: Revenue, 2018-2020, $ bn 110
Table 48. Lonza Group: Company Snapshot 111
Table 49. Lonza Group: Business Segmentation in 2018 111
Table 50. Lonza Group: Product Portfolio 112
Table 51. Lonza Group: Revenue by Region in 2018 112
Table 52. Merck & Co., Inc.: Company Snapshot 114
Table 53. Merck & Co., Inc.: Business Segmentation 114
Table 54. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 115
Table 55. Mylan NV: Company Snapshot 116
Table 56. Mylan NV: Revenue, 2017-2019, $ bn 117
Table 57. Novartis International AG: Company Snapshot 118
Table 58. Novartis International AG: Business Segmentation 118
Table 59. Novartis International AG: Revenue, 2017-2019, $ bn 119
Table 60. Pfizer Inc.: Company Snapshot 120
Table 61. Pfizer Inc.: Business Segmentation 121
Table 62. Pfizer Inc.: Product Portfolio 122
Table 63. Pfizer Inc.: Revenue, 2018-2020, $ bn 122
Table 64. Sun Pharmaceutical Industries Limited: Company Snapshot 124
Table 65. Teva Pharmaceutical Industries Ltd.: Company Snapshot 127
Table 66. Teva Pharmaceutical Industries Ltd.: Business Segmentation 128
Table 67. WuXi AppTec Inc.: Company Snapshot 129
List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 17
Figure 4. Asia Pacific Small Molecule API Market, 2022-2032, $ mn 20
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Small Molecule API Market 30
Figure 7. Primary Restraints and Impact Factors of Asia Pacific Small Molecule API Market 34
Figure 8. Investment Opportunity Analysis 38
Figure 9. Porter’s Fiver Forces Analysis of Asia Pacific Small Molecule API Market 41
Figure 10. Breakdown of Asia Pacific Small Molecule API Market by Source, 2022-2032, % of Revenue 46
Figure 11. Asia Pacific Addressable Market Cap in 2023-2032 by Source, Value ($ mn) and Share (%) 46
Figure 12. Asia Pacific Small Molecule API Market by Source: Synthetic API, 2022-2032, $ mn 47
Figure 13. Asia Pacific Small Molecule API Market by Synthetic API: Branded Synthetic API, 2022-2032, $ mn 48
Figure 14. Asia Pacific Small Molecule API Market by Synthetic API: Generic Synthetic API, 2022-2032, $ mn 49
Figure 15. Asia Pacific Small Molecule API Market by Source: Semi-synthetic API, 2022-2032, $ mn 50
Figure 16. Asia Pacific Small Molecule API Market by Source: Natural Origin, 2022-2032, $ mn 51
Figure 17. Breakdown of Asia Pacific Small Molecule API Market by Product Type, 2022-2032, % of Sales Revenue 53
Figure 18. Asia Pacific Addressable Market Cap in 2023-2032 by Product Type, Value ($ mn) and Share (%) 53
Figure 19. Asia Pacific Small Molecule API Market by Product Type: Standard API, 2022-2032, $ mn 54
Figure 20. Asia Pacific Small Molecule API Market by Product Type: High Potency API (HPAPI), 2022-2032, $ mn 55
Figure 21. Asia Pacific Small Molecule API Market by HPAPI: Branded HPAPI, 2022-2032, $ mn 56
Figure 22. Asia Pacific Small Molecule API Market by HPAPI: Generic HPAPI, 2022-2032, $ mn 57
Figure 23. Breakdown of Asia Pacific Small Molecule API Market by Therapeutic Area, 2022-2032, % of Sales Revenue 59
Figure 24. Asia Pacific Addressable Market Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%) 59
Figure 25. Asia Pacific Small Molecule API Market by Therapeutic Area: Infectious Diseases, 2022-2032, $ mn 60
Figure 26. Asia Pacific Small Molecule API Market by Therapeutic Area: Oncology, 2022-2032, $ mn 61
Figure 27. Asia Pacific Small Molecule API Market by Therapeutic Area: Ophthalmology, 2022-2032, $ mn 62
Figure 28. Asia Pacific Small Molecule API Market by Therapeutic Area: Cardiovascular Disorders, 2022-2032, $ mn 63
Figure 29. Asia Pacific Small Molecule API Market by Therapeutic Area: Central Nervous System, 2022-2032, $ mn 64
Figure 30. Asia Pacific Small Molecule API Market by Therapeutic Area: Respiratory Disorders, 2022-2032, $ mn 65
Figure 31. Asia Pacific Small Molecule API Market by Therapeutic Area: Metabolic Diseases, 2022-2032, $ mn 66
Figure 32. Asia Pacific Small Molecule API Market by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn 67
Figure 33. Breakdown of Asia Pacific Small Molecule API Market by Application, 2022-2032, % of Revenue 69
Figure 34. Asia Pacific Addressable Market Cap in 2023-2032 by Application, Value ($ mn) and Share (%) 69
Figure 35. Asia Pacific Small Molecule API Market by Application: Clinical Use, 2022-2032, $ mn 70
Figure 36. Asia Pacific Small Molecule API Market by Application: Commercial Use, 2022-2032, $ mn 71
Figure 37. Breakdown of Asia Pacific Small Molecule API Market by Manufacturer Type, 2022-2032, % of Revenue 73
Figure 38. Asia Pacific Addressable Market Cap in 2023-2032 by Manufacturer Type, Value ($ mn) and Share (%) 73
Figure 39. Asia Pacific Small Molecule API Market by Manufacturer Type: Pharmaceutical Companies, 2022-2032, $ mn 74
Figure 40. Breakdown of Asia Pacific Small Molecule API In-house Synthesis Market by Region, 2020-2027, % of Revenue 75
Figure 41. Asia Pacific Small Molecule API Market by Manufacturer Type: CMOs, 2022-2032, $ mn 76
Figure 42. Breakdown of Asia Pacific Small Molecule API Contract Synthesis Market by Region, 2020-2027, % of Revenue 77
Figure 43. Breakdown of APAC Small Molecule API Market by Country, 2022 and 2032, % of Revenue 79
Figure 44. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 80
Figure 45. Small Molecule API Market in Japan, 2022-2032, $ mn 82
Figure 46. Small Molecule API Market in China, 2022-2032, $ mn 84
Figure 47. Small Molecule API Market in Australia, 2022-2032, $ mn 86
Figure 48. Small Molecule API Market in India, 2022-2032, $ mn 88
Figure 49. Small Molecule API Market in South Korea, 2022-2032, $ mn 90
Figure 50. Small Molecule API Market in Rest of APAC, 2022-2032, $ mn 92
Figure 51. Growth Stage of Asia Pacific Small Molecule API Industry over the Forecast Period 94
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|